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Mitochondria are highly dynamic and structurally
complex organelles that provide multiple essential
metabolic functions. Mitochondrial dysfunction is
associated with neurodegenerative conditions such as
Parkinson’s disease, as well as bacterial infection. Here,
we explore the roles of mitochondrial autophagy
(mitophagy) and the mitochondrial unfolded protein
response (UPRmt) in the response to mitochondrial
dysfunction, focusing in particular on recent evidence
on the role of mitochondrial import efficiency in the
regulation of these stress pathways and how they
may interact to protect the mitochondrial pool while
initiating an innate immune response to protect
against bacterial pathogens.space, inner membrane or matrix. To enter the matrix,
the protein crosses the inner membrane through theMitochondria are dynamic cellular compartments respon-
sible for numerous essential cellular processes including
energy production via oxidative phosphorylation and
amino acid and nucleic acid metabolism, as well as the
regulation of apoptosis. These double-membrane-bounded
organelles are composed of over 1,000 proteins, most of
which are encoded in the nuclear genome, with the rest
encoded in the mitochondrial genome. As a direct conse-
quence of their function as the site of oxidative phosphor-
ylation, mitochondria are also a primary site of reactive
oxygen species (ROS) generation. Combined, these mito-
chondrial features present considerable challenges both to
organelle assembly and to the maintenance of homeostasis.
In this review, we focus on the role of mitochondrial im-
port efficiency in the regulation of two mitochondrial stress* Correspondence: haynesc@mskcc.org
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article, unless otherwise stated.response pathways and their roles in neurodegeneration
and bacterial infection.
Thirteen essential components of the respiratory chain,
and ATP synthase, which catalyzes the final step in the
generation of ATP, are encoded by the mitochondrial
genome (mtDNA). They are translated on mitochondrial
ribosomes and directly inserted into the mitochondrial
inner membrane [1]. Mitochondrial proteins encoded in
the nucleus and translated on cytosolic ribosomes by con-
trast must be targeted to the mitochondria and subse-
quently imported (Figure 1A). In most cases the targeting
is achieved by an amino-terminal mitochondrial targeting
sequence (MTS), although internal sequences also exist
[2]. Once at the mitochondrial outer membrane, the
protein is directed to the appropriate mitochondrial
subcompartment: the outer membrane, intermembrane
TIM (translocase of inner membrane) complex, where
the MTS is cleaved and the protein folds and assembles
into its functional conformation. Crossing the inner
membrane requires both a membrane potential, which
is generated by a functional respiratory chain, and mo-
lecular chaperones located in the mitochondrial matrix
(Figure 1A). Mitochondrial protein import is disrupted
in multiple pathologic states, and is emerging as a
central regulatory step affecting metabolism and stress
responses [3].
In particular, the upstream regulatory proteins that
modulate both mitochondrial autophagy (mitophagy) and
the mitochondrial unfolded protein response (UPRmt) are
regulated by mitochondrial protein import efficiency; thus,
because mitochondrial import requires multiple mito-
chondrial functions, import efficiency can provide a
useful readout of individual organelle function as well as
the function of the entire organelle pool. We begin by
reviewing the role of import regulation in these two
stress responses.d Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
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Figure 1. Mitochondrial protein import and PINK1-mediated mitophagy. (A) The vast majority of mitochondrial proteins are encoded by
nuclear genes, synthesized on cytosolic ribosomes and targeted to mitochondria via mitochondrial targeting sequences (MTS). To reach the
mitochondrial matrix, proteins synthesized on cytosolic ribosomes first interact with the translocase of the outer membrane (TOM) and then with
the translocase of the inner membrane (TIM). Crossing the inner membrane requires both complexes, a membrane potential (Ψ) across the inner
mitochondrial membrane that is generated by the respiratory chain, ATP and molecular chaperones (CH) within the mitochondrial matrix. Once
in the matrix, the MTS is typically cleaved, allowing the protein to fold and assemble appropriately. Perturbations to the TOM/TIM complexes,
respiratory chain, membrane potential and mitochondrial chaperones results in reduced mitochondrial import efficiency. (B) The kinase PINK1
serves to monitor mitochondrial health and initiate mitochondrial degradation when an organelle is severely damaged. Normally, PINK1,
localized to mitochondria by its MTS sequence, is efficiently imported into the mitochondrion and subsequently degraded. However, when a
mitochondrion is damaged (red), resulting in a depleted inner membrane potential or because of high levels of unfolded proteins in the matrix,
PINK1 fails to be imported and accumulates on the mitochondrial outer membrane, allowing recognition of the damaged organelle in a
sequence of steps, the first of which is the recruitment of the ubiquitin ligase Parkin to the outer mitochondrial membrane. PINK1 phosphorylates
ubiquitin (Ub) and the ubiquitin ligase Parkin, and activated Parkin then ubiquitinates outer mitochondrial membrane proteins, leading to the
recruitment of the autophagosome machinery and engulfment of the damaged organelle. Precise engulfment requires the Rab GAP TBC1D15
(shown in grey), which is bound to the mitochondrial outer membrane via interaction with LC3/GABARAP (not shown). The autophagosome
then fuses with a lysosome, leading to degradation of the defective mitochondria by the proteases and lipases that reside in lysosomes.
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Mitophagy is a form of autophagy that specifically elimi-
nates damaged mitochondria (Figure 1B). Mitophagy is
regulated by the kinase PINK1 and the ubiquitin ligase
Parkin, proteins encoded by genes that when mutated
lead to early onset Parkinsonism [4-6]. Recognition and ul-
timately selection of defective mitochondria are initiated by
PINK1, which contains an amino-terminal MTS [7]. Nor-
mally, PINK1 is imported into mitochondria where the
MTS is processed in the matrix and the kinase is ultimately
degraded by mitochondrial and cytosolic proteases [8,9].
However, during mitochondrial unfolded protein stress,
caused by overexpression of a misfolded mitochondrial
protein [10], depletion of a mitochondrial chaperone [11],or when the mitochondrial inner membrane potential is
severely depleted, PINK1 fails to cross the inner membrane
and integrates into the mitochondrial outer membrane
[12,13] (Figure 1B). With its kinase domain exposed to the
cytosol [14], PINK1 subsequently recruits Parkin from the
cytosol [12,13] and activates its ubiquitin ligase activity by
phosphorylating Parkin in its amino-terminal ubiquitin-
like domain at serine 65 [15]. PINK1 also phosphorylates
free ubiquitin as well as poly-ubiquitin at serine 65, which
is also required for Parkin activation [16-18]. Parkin ac-
tivation requires phosphorylation of its ubiquitin-like
domain by PINK1, which allows binding to PINK1-
phosphorylated ubiquitin. It is believed that the role of
phosphorylated ubiquitin is to interact with Parkin, thus
releasing Parkin’s autoinhibitory domain [19] and exposing
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quitinate multiple mitochondrial proteins [20]. In addition
to phosphorylating free ubiquitin, PINK1 also phosphory-
lates poly-ubiquitin chains conjugated to mitochondrial
proteins by Parkin. This activity generates a feed forward
mechanism by recruiting phosphorylated Parkin and
amplifying substrate ubiquitination and ubiquitin chain
synthesis [21]. The accumulation of poly-ubiquitin chains
leads to the disposal of the defective organelle in lysosomes
(Figure 1B).
While PINK1 and Parkin are at the core of the mito-
phagy pathway, a number of additional components, many
identified in a recent RNA interference screen [22], are
required for their translocation and assembly at the outer
mitochondrial membrane. TOMM7, a component of the
translocase of the outer membrane (TOM), which medi-
ates translocation of proteins encoded in the nucleus,
is required for PINK1 accumulation and stabilization in
the outer membrane during mitochondrial dysfunction.
Parkin recruitment seems to require both chaperones and
metabolic signals. For example, the HSP70 family member
HSPA1L and BAG4, a HSP70 nucleotide exchange factor
and hexokinases are required for Parkin recruitment, indi-
cating the need for cytosolic chaperone activity [22] and
possibly implicating aspects of glucose metabolism in the
regulation of mitophagy [23].
Mitochondria, long thought of as discrete organelles,
are now known to be a network constantly undergoing fu-
sion and fission, in which segments of the network can be
isolated by fission. Mitochondrial fission functions down-
stream of Parkin recruitment to promote mitophagy. Fis-
sion requires the dynamin related protein Drp1 and allows
the isolation of severely damaged mitochondrial segments
and generation of mitochondria of a size compatible
with the autophagosome and lysosome [24-26]. Parkin
recruitment promotes fission by ubiquitinating and tar-
geting a mitochondrial fusion component for degrad-
ation [27]. The generation of the mitochondria-specific
pre-autophagosomal isolation membrane (Figure 1B) is
regulated by TBC1D15, a mitochondrial Rab GTPase-
activating protein (Rab-GAP) [28] and the mitochondrial
outer membrane protein Fis1 [29]. To match autophago-
some size to that of its defective mitochondrial cargo,
TBC1D15 inhibits or slows Rab7, a GTPase activated by
Parkin that promotes autophagosome membrane expan-
sion. TBC1D15 also associates with the mitochondrial
outer membrane protein Fis1 and the autophagosomal
isolation membrane through interactions with LC3/
GABARAP (Figure 1B). Once autophagosome formation
is complete, the autophagosome fuses with a lysosome
and empties its contents into the lysosome interior, where
the damaged mitochondria are degraded.
In addition to the regulation of PINK1 by mitochondrial
protein import efficiency, additional layers of mitophagyregulation exist to promote the appropriate activation of
Parkin activity. The mitochondrial-localized deubiquitinase
USP30 [30] as well as the anti-apoptotic Bcl-2 family pro-
teins were recently shown to antagonize Parkin activity
[31,32]. Parkin recruitment to mitochondria leads to the
ubiquitination of many mitochondrial proteins. And, ubi-
quitination of mitochondrial proteins by Parkin is antago-
nized by USP30, suggesting that the deubiquitinase may
limit aberrant ubiquitination, thus ensuring that mitophagy
results only in the degradation of defective organelles [31].
Bcl-2 proteins regulate apoptosis, ultimately coordinating
permeabilization of the outer mitochondrial membrane and
the release of proteins such as cytochrome c from the inter-
membrane space into the cytosol. In addition to impairing
apoptosis, the pro-survival Bcl-2 proteins impair mitophagy
by directly binding Parkin and impairing its translocation
to defective mitochondria, suggesting the anti-apoptotic
proteins promote mitochondrial network integrity by
impairing mitophagy and membrane permeabilization
in the absence of pro-apoptotic stimuli [32].
Regulation of the UPRmt by mitochondrial protein
import efficiency
The UPRmt is a protective or adaptive transcriptional re-
sponse that promotes survival during mitochondrial stress
or dysfunction. It was first documented in cultured mam-
malian cells by depleting mtDNA with ethidium bromide
[33] or by overexpressing a folding incompetent form
of ornithine transcarbamylase and targeting it to the
mitochondrial matrix [34]. In response, mitochondrial
chaperone and protease genes [35] are transcribed and
presumably stabilize the mitochondrial protein-folding
environment [36,37].
While induction of a UPRmt in mammals occurs during
multiple forms of mitochondrial stress, the means of regu-
lation is unclear. Mitochondria-to-nucleus communication
in mammalian cells is thought to require the transcription
factor CHOP [34], and more recently, the mitochondrial
sirtuin SirT3 was found to regulate UPRmt activity via dea-
cetylation of the transcription factor FOXA3, promoting
its accumulation in the nucleus and allowing expression of
anti-oxidant genes [38]. The estrogen receptor has also
been shown to respond to mitochondrial stress to stabilize
the protein folding environment in the mitochondrial
intermembrane space through the transcriptional up-
regulation of mitochondrial protease Omi and increase
in cytosolic proteasomal activity [38,39].
Regulation of the UPRmt is much better understood in
Carnorhabditis elegans, in which it is regulated by the
bZip transcription factor ATFS-1, first identified in a
genome-wide screen for genes required for the transcrip-
tional induction of mitochondrial chaperones during mito-
chondrial stress [40]. Like PINK1, ATFS-1 has an amino-













Figure 2. The ATFS-1-mediated mitochondrial unfolded protein response. The UPRmt is a protective transcriptional response to the
accumulation of unfolded proteins or respiratory chain dysfunction that promotes adaptation and survival during mitochondrial dysfunction.
Cells utilize the transcription factor ATFS-1 to monitor mitochondrial function and adjust transcription accordingly. Like PINK1, ATFS-1 is
imported into mitochondria and quickly degraded in healthy cells, but accumulates in the cytosol during mitochondrial stress due to respiratory
chain dysfunction, unfolded protein accumulation or high levels of reactive oxygen species, when mitochondrial import efficiency is impaired.
Because ATFS-1 has a nuclear localization sequence (NLS), as well as its mitochondrial localization sequence (MTS), this causes it to localize to
the nucleus, where it induces the transcription of genes involved in mitochondrial protein homeostasis, reactive oxygen species (ROS) and small
molecule detoxification, glycolysis, and innate immunity.
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Lon protease [9,13,41]. However, unlike PINK1, ATFS-1
also has a nuclear localization sequence. Where mitochon-
drial dysfunction is caused by impairment of mitochon-
drial chaperones and proteases, mutations to respiratory
chain genes [41,42], exposure to respiratory chain inhibi-
tors, including antimycin [43-45], mitochondrial ribosome
impairment [46], high levels of ROS, or exposure to eth-
idium bromide [44,47], mitochondrial import efficiency
is slowed [45], causing ATFS-1 to accumulate in the
cytosol [41] (Figure 2). Because of its nuclear localization
sequence, rather than being degraded in the cytosol [45],
ATFS-1 migrates to the nucleus where it induces tran-
scription of over 400 genes that constitute the UPRmt.
Included in this transcriptional program are mitochondrial
proteases and chaperones, mitochondrial fission compo-
nents, the mitochondrial protein import machinery, anti-
oxidant genes and the glycolysis machinery [41].
While many details remain to be elucidated, the tran-
scriptional output of the UPRmt is consistent with a
program that promotes survival during mitochondrial
dysfunction by adapting metabolism while stabilizing
the defective but salvageable organelles to facilitate re-
pair or regeneration.
Mitophagy and UPRmt interactions
It is clear that mitochondrial accumulation of PINK1
and activation of ATFS-1 can occur under the same con-
ditions [10,11,41,44,47]; to our knowledge, however, the
potential pathway interactions have not been examined
simultaneously, although enough data exist to suggest
these pathways interact in a complementary fashion.Presumably, mitophagy serves to remove the most se-
verely defective organelles (Figure 3) while the UPRmt pro-
motes stabilization and recovery of those organelles that
are salvageable [36]. While mitochondria are known to
comprise a dynamic network, at a given point in time they
form a pool of at least semi-independent cellular compart-
ments, and it is clear that PINK1 and Parkin specifically
accumulate on individual defective organelles: this has
been shown in cells bearing a mixture of normal mito-
chondrial DNA and DNA bearing a deleterious mutation
(so-called heteroplasmic cells) [48]. ATFS-1 by contrast
serves as a sensor for general levels of mitochondrial
stress. Because mitochondrial import is post-translational
[49], ATFS-1 accumulates in the cytosol and ultimately
the nucleus in proportion to the level of mitochondrial
stress throughout the cell. This could reflect a mixture of
dysfunctional and healthy mitochondria, or equal levels of
stress to all mitochondria (Figure 3). A number of the
protein products of genes whose transcription is in-
duced by ATFS-1 must be imported into mitochondria
in order to promote organelle recovery. We hypothesize
that because the healthiest mitochondria are the most
import competent, the UPRmt is likely to promote the
recovery of those organelles that can be salvaged. Con-
comitantly, by culling the most defective organelles,
PINK1-dependent mitophagy enriches the pool of
healthy (or least defective) organelles, reducing aberrant
ROS production and the loss of resources that would be
wasted attempting to recover unsalvageable organelles
[50]. It will be interesting to see whether there is indeed
crosstalk and interaction between the pathways to
optimize their complementary effects.
PINK1-dependent Mitophagy ATFS-1-dependent UPRmt
Stress per mitochondrion Total cellular mitochondrial stress
Figure 3. Integrating mitophagy and the UPRmt. While mitochondria are dynamic, at a given point in time they form a pool of at least
semi-independent cellular compartments. Because PINK1 specifically accumulates on individual defective organelles (red), the mitophagy pathway
is well equipped to monitor the health of individual organelles. On the other hand, ATFS-1 accumulates in the cytosol in proportion to the total
amount of cellular mitochondrial stress. Because mitochondrial protein import is post-translational, ATFS-1 can accumulate in the cytosol during
conditions where multiple individual mitochondria are severely defective (red; middle panel), or if the total pool of organelles is modestly stressed
(far right panel). ATFS-1 induces transcription of a number of genes whose protein products must be imported into mitochondria to promote
their recovery. Because the healthiest organelles are the most import competent, the UPRmt likely promotes the recovery of those organelles that
can be salvaged. Concomitantly, by culling the most defective organelles, PINK1-dependent mitophagy enriches the healthy pool of organelles,
allowing the resources required for mitochondrial repair to be allocated to the salvageable mitochondrial population.
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Parkinson’s disease is characterized by dopaminergic neur-
onal death in the substantia nigra region of the brain. The
majority of cases of Parkinson’s disease are sporadic and
develop late in life, and although there are associations of
the disease with exposure to environmental toxins, the
underlying causes remain unclear. Roughly 10% of all
cases, however, are caused by genetic defects, which lead
to early onset Parkinson’s disease. These include muta-
tions in the genes encoding PINK1 and Parkin [4-6].
While mitophagy is well studied in cell culture models,
documenting mitochondrial degradation due specifically
to PINK1 or Parkin has been difficult in vivo, particu-
larly in vertebrates [51]. However, a number of recent
studies in mice and rats lacking PINK1 or Parkin have
demonstrated physiologic defects consistent with im-
paired mitophagy. Striatal neurons of Parkin-deficient
mice have respiratory chain defects [52] and PINK1-
deficient mice have been found to be susceptible to
forms of mitochondrial stress such as overexpression of
misfolded mitochondrial proteins resulting in neuron
loss [53,54]. Significantly, PINK1-deficient rats display
nigral degeneration coupled with motor deficits, suggest-
ing this model may be physiologically quite similar to the
human mutations [55].
Early studies in Drosophila remain the strongest exam-
ples of PINK1 or Parkin deficiency causing mitochon-
drial dysfunction and consequent physiological defects,
because in flies these proteins are required for homeo-
stasis even in the absence of stress, and the phenotypeis much stronger. Thus, flies lacking either enzyme have
severe flight muscle and spermatozoa dysfunction along
with defects in mitochondrial morphology, all of which
are at least consistent with impaired mitophagy [56-58].
This is also consistent with studies on axons of rat pri-
mary neurons showing that PINK1 and Parkin mediate
the degradation of defective mitochondria via mitophagy
[59]. In axons, mitophagy may be more important than
organelle repair, because the axon can extend for a consid-
erable distance from the cell body: lysosome-dependent
degradation in these studies occurred in the axon rather
than by transport back to the cell body.
In addition to the degradation of whole organelles,
PINK1 and Parkin are required for the generation of
mitochondria-derived vesicles (MDVs), which transport
damaged mitochondrial components to the endomem-
brane system and ultimately the lysosome for degrad-
ation [60-62]. MDVs can contain oxidized material from
the mitochondrial outer membrane, but also the inner
membrane and matrix. It is thus possible that PINK1
senses localized mitochondrial damage or damaged mito-
chondrial subcompartments in a manner similar to that
by which it regulates mitophagy via mitochondrial im-
port deficiency, but rather than degrade the entire or-
ganelle, MDVs are generated to specifically remove the
damaged segments. Vps35, a protein that participates
in a number of membrane trafficking events, has also
been implicated in MDV formation and has recently
been linked to Parkinson’s disease [63,64]. Interestingly,
a separate study has also implicated PINK1 and Parkin
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[65]. It should be noted that in addition to mitochon-
drial quality control, PINK1 has been found to have
roles in mitochondrial dynamics [66-68], mitochondrial
transport and positioning in neurons [69,70], and regu-
lating the assembly and activity of complex I of the
respiratory chain [71], which may also account for the
observed mitochondrial dysfunction in cells and organ-
isms lacking PINK1.
Roles for the UPRmt in Parkinson’s disease are emerging
but remain circumstantial, possibly because UPRmt regula-
tion is not well understood in mammals. Compounds or
mutations that cause mitochondrial dysfunction and Par-
kinson’s-like symptoms, such as the respiratory complex I
inhibitor rotenone and the superoxide generator paraquat,
strongly induce the UPRmt [41,44,72]. And ATFS-1 is re-
quired for animal development during these conditions
[42], suggesting a protective role during Parkinson’s-associated
mitochondrial stress, but considerable work remains
to establish a connection.
Bacterial pathogenesis
A number of bacteria and bacterial pathogens secrete pro-
tein or toxin virulence factors that perturb mitochondrial
function to promote proliferation and infection [73-79].
For example, species of Streptomyces produce the respira-
tory chain complex III inhibitor antimycin and the ATP
synthase inhibitor oligomycin [80], and the human patho-
gen Pseudomonas aeruginosa produces the complex IV in-
hibitor cyanide as well as a number of iron chelators that
also perturb mitochondrial function [81,82]. Conversely,
mitochondria have a number of roles in resistance against
bacterial infection, including the production of bactericidal
ROS [83] and inflammasome activation [84]. Interestingly,
recent work from a number of laboratories has indicated
protective roles for mitophagy and UPRmt components
during bacterial infection.
Work in C. elegans has indicated that perturbation of
mitochondrial function by exposure to toxins or by RNA
interference-mediated knockdown of mitochondrial genes
induces an innate immune response [43,85-87]. Exposure
to P. aeruginosa, which affects mitochondrial function as
well as numerous other cellular functions, eventually col-
onizing the intestinal lumen and killing the worm, induces
innate immune responses similar to those induced by
mitochondrial dysfunction, suggesting a link between
bacterial infection, mitochondrial stress and the UPRmt.
Indeed, upon exposure to P. aeruginosa, mitochondrial
chaperone and secreted lysozyme gene transcription is
specifically induced in the intestine. The UPRmt is not
induced when the worms are exposed to P. aeruginosa
lacking the global virulence activator gene gacA, as well
as genes required for cyanide and iron chelator produc-
tion, indicating that mitochondrial perturbation is causedby pathogen virulence. Importantly, ATFS-1 impairment
increases susceptibility to P. aeruginosa, which is consist-
ent with a role for ATFS-1 in protective innate immunity.
Interestingly, when worms were individually fed over 500
bacterial strains, only 18% caused UPRmt activation [43],
including a number of potentially pathogenic bacteria spe-
cies such as Pseudomonas and Enterobacteriaceae, sug-
gesting the possibility that ATFS-1 and the UPRmt is a
means to detect and ultimately eliminate those pathogens
that target mitochondrial function [87]. Innate immune
responses initiated by pathways in place to monitor
intracellular dysfunction may be especially important in
microbe-rich environments such as the intestine where
distinguishing pathogenic from commensal bacteria may
be particularly challenging [86,88-90].
In addition to the UPRmt, roles for PINK1 and Parkin
during pathogen infection have been identified. A study
in C. elegans demonstrated a requirement for PINK1
and mitophagy in the degradation of those mitochondria
damaged by P. aeruginosa-produced siderophores [82].
Additionally, multiple gene association studies in patients
have shown a link between loss-of-function mutations in
the gene encoding Parkin with increased susceptibility to
the intracellular pathogenic bacteria Mycobacterium leprae
and Salmonella enterica, which cause leprosy and typhoid
fever, respectively [91-93]. More recently, Parkin deficient
cells, mice and flies have been found to be susceptible to
Mycobacterium tuberculosis [94]. M. tuberculosis prolifer-
ation is increased in macrophages with defective Parkin
[94]. And, also in macrophages, Parkin was found to co-
localize with the bacteria, where it ubiquitinates phago-
somal vesicles, targeting them for lysosomal degradation
in a manner strikingly similar to mitophagy. It is currently
unclear if PINK1 is required for Parkin’s role in targeting
pathogenic bacteria for lysosomal degradation but it seems
unlikely as there is no obvious means for PINK1 to inter-
act with the pathogen [95]. It will be interesting to deter-
mine how Parkin is localized to intracellular pathogens
and if there is another ubiquitin kinase that contributes to
activation of Parkin in this context.
Therapeutic considerations
Several recent discoveries about the regulation of mito-
phagy and the UPRmt have suggested therapeutic strat-
egies to promote the overall health of the mitochondrial
network and limit Parkinson’s disease progression or
bacterial infection. While Parkin ubiquitinates defective
mitochondria, the mitochondrial deubiquitinase USP30
[30] limits Parkin activity by removing mitochondrial
ubiquitin as a form of negative regulation. USP30 inhib-
ition results in increased ubiquitination of dysfunctional
mitochondria, resulting in increased mitophagy and protec-
tion from mitochondrial dysfunction in cultured mamma-
lian neurons as well as in flies exposed to the mitochondrial
Note: This article is part of the series on mitochondria edited
by Martin Brand, Navdeep Chandel, Andrew Murray, Jodi
Nunnari and Peter Walter. Other articles in this series can be
found at http://www.biomedcentral.com/series/Mitochondria
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limit mitochondrial import of ATFS-1, thus causing hyper-
activation of the UPRmt [96], result in increased innate
immune gene and mitochondrial-protective gene expres-
sion, yielding increased survival on paraquat and ethidium
bromide. Hyper-activation of the UPRmt also increases in-
testinal pathogen clearance and survival during exposure to
P. aeruginosa [87].
Several recent reports have demonstrated multiple means
by which the defects associated with PINK1 deficiency can
be alleviated, suggesting strategies to improve PINK1 func-
tion in patients with PINK1 loss-of-function mutations, but
also in Parkinson’s patients with an intact mitophagy path-
way. PINK1, for example, has been reported to be the rare,
and perhaps the only, kinase that preferentially accepts the
ATP analog kinetin triphosphate (KTP) with higher cata-
lytic efficiency than its normal substrate ATP in vitro [97].
Impressively, treatment of cells with the clinically available
KTP precursor kinetin resulted in increased intracellular
KTP, which alleviated many of the defects found in PINK1-
deficient cells, including Parkin recruitment, mitophagy,
and mitochondrial motility.
The main focus of this article has been the mechanisms
of mitochondrial quality control; but as mentioned earlier,
PINK1 is also important for other aspects of mitochondrial
function. Two of these in particular have been the target of
alternative strategies for correcting PINK1-deficiency that
are aimed not at promoting the destruction of defective
mitochondria but at improving or altering mitochondrial
function. In one case, the target has been respiratory
competency, to which PINK1 is believed to contribute.
As in bacteria, vitamin K2 promotes electron transfer in
the metazoan respiratory chain, and by taking advantage
of the strong Drosophila PINK1-deficient phenotype,
it has been possible to show that overexpression of
the gene Heix or UBIAD1, which is involved in vitamin
K2 synthesis, can correct many of the defects consequent
on PINK1 deficiency [98]. In a second case, the target is
nucleotide metabolism, whose disruption is also impli-
cated in the consequences of PINK1 deficiency. In Parkin-
son’s disease patients, transcripts of proteins involved
in nucleotide metabolism are increased in neurons. This
has recently been shown also to occur in the neurons of
PINK1-deficient flies [99], possibly driven by a stress re-
sponse similar to a UPRmt [100]. Overexpression of these
genes as well as pharmacological enhancement of the nu-
cleotide salvage pathways by folate treatment (or supple-
ment with all four nucleotides) rescued the mitochondrial
impairment in PINK1-deficient flies, suggesting thera-
peutic potential [99].
Considerable insight has been gained into how cells
cope with mitochondrial dysfunction, but as we continue
to learn more about these and other pathways, there is
little doubt that more therapeutic avenues will open. Inthe future, it will perhaps be interesting to combine
strategies to simultaneously activate both mitophagy and
the UPRmt [99] to determine if positive effects of each
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